Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats: Laboratory investigation

Journal of Neurosurgery

Volumn 113, Issue 3, 2010, Pages 648-655

  Higashida, Tetsuhiro ^a   Jitsuki, Susumu ^a   Kubo, Atsuhiko ^a   Mitsushima, Dai ^a   Kamiya, Yoshinori ^a   Kanno, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Dopamine; Microdialysis; Parkinson disease; Skin derived precursors; Von Hippel Lindau protein

Indexed keywords

APOMORPHINE; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE; VON HIPPEL LINDAU PROTEIN; DOPAMINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EXTRACELLULAR MATRIX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICRODIALYSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSON DISEASE; PRECURSOR; PRIORITY JOURNAL; RAT; SKIN DERIVED PRECURSOR; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CHEMICALLY INDUCED; CONVALESCENCE; CYTOLOGY; EXTRACELLULAR SPACE; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; MALE; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PARKINSONIAN DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; STEM CELL; STEM CELL TRANSPLANTATION; WISTAR RAT;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CORPUS STRIATUM; DOPAMINE; EXTRACELLULAR SPACE; MALE; NEUROGENESIS; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; STEM CELL TRANSPLANTATION; STEM CELLS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 77956911591     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.2.JNS091432     Document Type: Article

References (38)

1. Bjorklund LM, Sánchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, et al: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 99:2344-2349, 2002
2. Daadi MM, Weiss S: Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain. J Neurosci 19:4484-4497, 1999
3. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, et al: Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113:1701-1710, 2004
4. Drucker-Colín R, Verdugo-Díaz L: Cell transplantation for Parkinson's disease: present status. Cell Mol Neurobiol 24: 301-316, 2004
5. Fernandes KJ, McKenzie IA, Mill P, Smith KM, Akhavan M, Barnabé-Heider F, et al: A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 6:1082-1093, 2004
6. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719, 2001
7. Gage FH: Cell therapy. Nature 392 (6679 Suppl):18-24, 1998
8. Gu F, Hata R, Ma YJ, Tanaka J, Mitsuda N, Kumon Y, et al: Suppression of Stat3 promotes neurogenesis in cultured neural stem cells. J Neurosci Res 81:163-171, 2005
9. Hagell P, Cenci MA: Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective. Brain Res Bull 68:4-15, 2005
10. Hashitani T, Mizukawa K, Kumazaki M, Nishino H: Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts. Neurosci Res 30:43-52, 1998
11. Hunt DP, Morris PN, Sterling J, Anderson JA, Joannides A, Jahoda C, et al: A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin. Stem Cells 26:163-172, 2008
12. Kanno H, Nakano S, Kubo A, Mimura T, Tajima N, Sugimoto N: Neuronal differentiation of neural progenitor cells by intracellular delivery of synthetic oligopeptide derived from Von Hippel-Lindau protein. Protein Pept Lett 16:1291-1296, 2009
13. Kanno H, Saljooque F, Yamamoto I, Hattori S, Yao M, Shuin T, et al: Role of the von Hippel-Lindau tumor suppressor protein during neuronal differentiation. Cancer Res 60:2820-2824, 2000
14. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, et al: Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40, 2000
15. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr: Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269:1444-1446, 1995
16. Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, Lumelsky N, et al: Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56, 2002
17. Kubo A, Yoshida T, Kobayashi N, Yokoyama T, Mimura T, Nishiguchi T, et al: Efficient generation of dopamine neuron-like cells from skin-derived precursors with a synthetic peptide derived from von Hippel-Lindau protein. Stem Cells Dev 18:1523-1532, 2009
18. Levy YS, Stroomza M, Melamed E, Offen D: Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. J Mol Neurosci 24:353-386, 2004
19. Li Y, Chen J, Wang L, Zhang L, Lu M, Chopp M: Intracerebral transplantation of bone marrow stromal cells in a 1-methyl- 4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 316:67-70, 2001
20. Maeda K, Kanno H, Yamazaki Y, Kubo A, Sato F, Yamaguchi Y, et al: Transplantation of Von Hippel-Lindau peptide delivered neural stem cells promotes recovery in the injured rat spinal cord. Neuroreport 20:1559-1563, 2009
21. Master Z, McLeod M, Mendez I: Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease. J Med Ethics 33:169-173, 2007
22. Mitsushima D, Masuda J, Kimura F: Sex differences in the stress-induced release of acetylcholine in the hippocampus and corticosterone from the adrenal cortex in rats. Neuroendocrinology 78:234-240, 2003
23. Mitsushima D, Yamada K, Takase K, Funabashi T, Kimura F: Sex differences in the basolateral amygdala: the extracellular levels of serotonin and dopamine, and their responses to restraint stress in rats. Eur J Neurosci 24:3245-3254, 2006
24. Murata H, Tajima N, Nagashima Y, Yao M, Baba M, Goto M, et al: Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells. Cancer Res 62:7004-7011, 2002
25. Ohh M, Takagi Y, Aso T, Stebbins CE, Pavletich NP, Zbar B, et al: Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. J Clin Invest 104:1583-1591, 1999
26. Perry E, Tsruya R, Levitsky P, Pomp O, Taller M, Weisberg S, et al: TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3. Oncogene 23:8908-8919, 2004
27. Peterson AL, Nutt JG: Treatment of Parkinson's disease with trophic factors. Neurotherapeutics 5:270-280, 2008
28. Riaz SS, Bradford HF: Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: applications in cell replacement treatment for Parkinson's disease. Prog Neurobiol 76:257-278, 2005
29. Riederer P, Wuketich S: Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 38: 277-301, 1976
30. Rodríguez-Gómez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, et al: Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25:918-928, 2007
31. Santa-Olalla J, Covarrubias L: Basic fibroblast growth factor promotes epidermal growth factor responsiveness and survival of mesencephalic neural precursor cells. J Neurobiol 40: 14-27, 1999
32. Sawamoto K, Nakao N, Kakishita K, Ogawa Y, Toyama Y, Yamamoto A, et al: Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J Neurosci 21:3895-3903, 2001
33. Snyder BJ, Olanow CW: Stem cell treatment for Parkinson's disease: an update for 2005. Curr Opin Neurol 18:376-385, 2005
34. Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, et al: Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol 148:135-146, 1997
35. Tanaka Y, Kanno H, Dezawa M, Mimura T, Kubo A, Yamamoto I: The role of von Hippel-Lindau protein in the differentiation of neural progenitor cells under normoxic and anoxic conditions. Neurosci Lett 383:28-32, 2005
36. Toma JG, Akhavan M, Fernandes KJ, Barnabé-Heider F, Sadikot A, Kaplan DR, et al: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3: 778-784, 2001
37. Toma JG, McKenzie IA, Bagli D, Miller FD: Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23:727-737, 2005
38. Yamada H, Dezawa M, Shimazu S, Baba M, Sawada H, Kuroiwa Y, et al: Transfer of the von Hippel-Lindau gene to neuronal progenitor cells in treatment for Parkinson's disease. Ann Neurol 54:352-359, 2003